retatrutide fda status Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation What Is Retatrutide for Weight
Description
No diagnostic or therapeutic claims

however, the duration youll be on this medication depends on your unique biology and goals

Supply chain disruptions at Novo Nordisk and Eli Lilly facilities further delayed production

Retatrutide Side Effects: Phase 2 & Phase 3 Safety Data (2026) Published and reported safety data incidence rates for nausea, GI side effects, and the dysesthesia signal across retatrutide trials

Consulte el precio exacto con su farmacia preferida
